---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-104204"
form_type: "8-K"
ticker: "PRLD"
cik: "0001678660"
company_name: "Prelude Therapeutics Inc"
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T13:38:11.812657+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Prelude Therapeutics files $25M ATM equity offering via Jefferies

## Summary
- Filed prospectus supplement to sell up to $25M common stock under existing Sales Agreement with Jefferies LLC.
- Offering supplements prior $75M capacity; shares sold from time to time at market prices.
- Legal opinion from Morgan, Lewis & Bockius LLP filed as Exhibit 5.1.
- Proceeds intended for general corporate purposes; no specific use disclosed.

## SEC filing metadata
- accession: 0001193125-26-104204
- form_type: 8-K
- ticker: PRLD
- cik: 0001678660
- company_name: Prelude Therapeutics Inc
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1678660/000119312526104204/0001193125-26-104204-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1678660/000119312526104204/d916869d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-104204
- JSON: https://secwatch.observer/filing/0001193125-26-104204.json
- Plain text: https://secwatch.observer/filing/0001193125-26-104204.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.